# Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea

> **NCT02801656** · PHASE3 · WITHDRAWN · sponsor: **Memorial University of Newfoundland**

## Conditions studied

- Clostridium Difficile

## Interventions

- **BIOLOGICAL:** Fecal Microbiota Transplantation
- **DRUG:** Vancomycin
- **BIOLOGICAL:** Fecal Microbiota Transplantation Placebo
- **DRUG:** Vancomycin Placebo

## Key facts

- **NCT ID:** NCT02801656
- **Lead sponsor:** Memorial University of Newfoundland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-12-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-09-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not funded
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02801656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02801656, "Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02801656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*